134 related articles for article (PubMed ID: 2583247)
1. Agonist binding to M1 muscarinic receptors is sensitive to guanine nucleotides.
Flynn DD; Palermo N; Suarez A
Eur J Pharmacol; 1989 Oct; 172(4-5):363-72. PubMed ID: 2583247
[TBL] [Abstract][Full Text] [Related]
2. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
Bleakman D; Naftalin RJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):366-72. PubMed ID: 2900471
[TBL] [Abstract][Full Text] [Related]
3. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
4. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
Flynn DD; Mash DC
J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
6. Two affinity states of M1 muscarine receptors.
Potter LT; Ferrendelli CA; Hanchett HE
Cell Mol Neurobiol; 1988 Jun; 8(2):181-91. PubMed ID: 3409266
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptors in porcine caudate nucleus. II. Different effects of N-ethylmaleimide on [3H]cis-methyldioxolane binding to heat-labile (guanyl nucleotide-sensitive) sites and heat-stable (guanyl nucleotide-insensitive) sites.
Nukada T; Haga T; Ichiyama A
Mol Pharmacol; 1983 Nov; 24(3):374-9. PubMed ID: 6633504
[TBL] [Abstract][Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
9. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat.
Dennison RL; Anthony BL; Narayanan TK; Aronstam RS
Neuropharmacology; 1987 Aug; 26(8):1201-5. PubMed ID: 3116449
[TBL] [Abstract][Full Text] [Related]
10. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
11. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
12. Species difference in the muscarinic receptors of thoracic aorta.
Yamanaka K; Hashimoto S; Muramatsu I
J Pharmacol Exp Ther; 1986 Jun; 237(3):980-6. PubMed ID: 3754896
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P
Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of putative M1/M2 muscarinic receptors: implications for different receptor-effector coupling mechanisms.
Vickroy TW; Watson M; Yamamura HI; Roeske WR
Adv Exp Med Biol; 1984; 175():99-114. PubMed ID: 6208760
[No Abstract] [Full Text] [Related]
15. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
Lazareno S; Buckley NJ; Roberts FF
Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
17. Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1-m5 receptors.
van Giersbergen PL; Leppik R
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):166-72. PubMed ID: 7477439
[TBL] [Abstract][Full Text] [Related]
18. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
19. Changes in affinity states during down-regulation of muscarinic receptors in tracheal smooth muscle of organophosphate-treated swine.
Yang CM; Mohan PM; Dwyer TM; Farley JM
J Auton Pharmacol; 1988 Jun; 8(2):79-91. PubMed ID: 3170629
[TBL] [Abstract][Full Text] [Related]
20. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting.
Mattera R; Pitts BJ; Entman ML; Birnbaumer L
J Biol Chem; 1985 Jun; 260(12):7410-21. PubMed ID: 3838988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
